AQT_Logo_Corporatif_RGB.png
Jean Magny, PDG de Genius Solutions est élu PDG de l’année AQT – Banque Nationale 2024
April 24, 2024 22:11 ET | Association québécoise des technologies (AQT)
Jean Magny, PDG de Genius Solutions est élu PDG de l’année AQT – Banque Nationale 2024Charlevoix (Québec), le 24 avril 2024 – C’est avec fierté que l’AQT
sphericalinsightsoptionblue.png
Global Vaccine Adjuvants Market Size To Worth USD 1.51 Billion By 2033 | CAGR of 3.9%
April 17, 2024 08:00 ET | SPHERICAL INSIGHTS LLP
New York, United States , April 17, 2024 (GLOBE NEWSWIRE) -- The Global Vaccine Adjuvants Market Size is to Grow from USD 1.03 Billion in 2023 to USD 1.51 Billion by 2033, at a Compound Annual...
BION.png
Bion Announces Voluntary Share Surrender
April 02, 2024 08:34 ET | BION ENVIRONMENTAL TECHNOLOGIES INC
New York, NY, April 02, 2024 (GLOBE NEWSWIRE) -- Bion Environmental Technologies, Inc. (OTC QB: BNET), a leader in advanced livestock waste treatment technology and premium sustainable beef,...
MannkindLogoStackedPreferd.jpg
MannKind Announces CFO Transition
March 26, 2024 16:05 ET | MannKind
MANNKIND ANNOUNCES CFO TRANSITION
 Valneva Initiates P
Valneva Initiates Phase 1 Trial of Second-Generation Zika Vaccine Candidate
March 26, 2024 02:00 ET | VALNEVA
Saint-Herblain (France), March 26, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the initiation of a Phase 1 clinical trial to investigate the ...
BION.png
Bion Applies for OMRI Listing for Commercial 10-0-0 Nitrogen Fertilizer
March 12, 2024 10:44 ET | BION ENVIRONMENTAL TECHNOLOGIES INC
New York, NY, March 12, 2024 (GLOBE NEWSWIRE) -- Bion Environmental Technologies, Inc. (OTC QB: BNET), a developer of advanced livestock waste treatment and resource recovery technology, announced...
AMR Logo.png
Vaccine Adjuvants Market to Reach $1.5Billion Globally, By 2032 at 4% CAGR: Allied Market Research
March 12, 2024 09:02 ET | Allied Analytics LLP
Wilmington, New Castle, Delaware, March 12, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Vaccine Adjuvants Market by Product Type (Immunostimulants and Vehicles...
sphericalinsightsoptionblue.png
Global Recombinant Vaccine Market Size To Exceed USD 24.9 Billion By 2032 | CAGR of 11.75%
March 11, 2024 06:00 ET | SPHERICAL INSIGHTS LLP
New York, United States, March 11, 2024 (GLOBE NEWSWIRE) -- The Global Recombinant Vaccine Market Size is to Grow from USD 8.2 Billion in 2022 to USD 24.9 Billion by 2032, at a Compound Annual...
SoftServe Achieves A
SoftServe Achieves AWS Generative AI Competency as Inaugural Launch Partner
March 07, 2024 08:35 ET | SoftServe
AUSTIN, Texas, March 07, 2024 (GLOBE NEWSWIRE) -- SoftServe, a premier IT consulting and digital services provider, today announced that it has become an inaugural partner to obtain the Amazon Web...
image1.png
ACTG CROI Presentation Demonstrates Superiority of HepB-CpG Vaccine Over Conventional Hepatitis B Vaccine Among People Living With HIV Who Have Not Previously Responded to Vaccination
March 06, 2024 15:30 ET | ACTG
ACTG at CROI: HepB-CPG Vaccine Outperforms Standard Hepatitis B Vaccine for HIV Patients with Previous Vaccination Failures